Evidence map›Paper›PMID 41284201›Full record

ArticleAnnals of surgical oncology2026

Treatment Patterns and Prognosis of Cervical Cancer Patients Aged 65 and Older: A Population-Based Cohort Study.

Linying Liu, Suhong Zhuang, Jianfeng Zheng, Feishuang Lin, Xingyun Xie, Xiao Chen, Lijun Chen, Yao Lin, Yang Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Linying LiuDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Suhong ZhuangDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Jianfeng ZhengDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Feishuang LinDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Xingyun XieDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Xiao ChenDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Lijun ChenDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Yao LinDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
Yang SunDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China. sunyang@fjmu.edu.cn.ORCID http://orcid.org/0000-0002-1587-9797

Funding

Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province 2022Y2015the Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China 2022ZQNZD008
6 · The paper itself

Abstract

purposeTo describe treatment patterns and prognosis in elderly cervical cancer (CC) patients ( ≥ 65 years).

methodsA retrospective analysis was conducted using the Surveillance, Epidemiology, and End Results database (2000-2019). Propensity score matching (PSM) balanced baseline characteristics. Overall survival (OS) was assessed using Kaplan-Meier analysis and Cox models. The Cochran-Armitage trend test was used to examine age-related risks of cancer and noncancer-specific death.

resultsAmong 45,447 CC patients, 7,026 (15.3%) were elderly. Compared with young ( < 40 years) and middle-aged (40-64 years) patients, elderly patients presented with more local advanced disease (58.1% vs. 34.3% vs. 47.4%), and received less radical surgery treatment (11.2% vs. 26.6% vs. 21%). After PSM, elderly patients had worse survival than younger groups (hazard ratio [HR] = 1.91 vs. young; HR = 1.63 vs. middle-aged; p < 0.0001). Elderly patients who underwent surgery had superior OS across all stages compared with those without surgery (p < 0.0001). In early-stage, radical surgery was superior to radical radiotherapy (p < 0.0001) (5 year OS: 86.6 vs. 69.8%). In resectable LACC, radical surgery and radical radiotherapy were comparable (p > 0.05), whereas in unresectable LACC cases, radical surgery plus radiotherapy provided the highest 5 year OS rate (61.2%) and significantly improved survival (p

conclusionsElderly CC patients present with more advanced stage disease and receive less intensive treatment compared to younger patients. Surgery is feasible, and individualized strategies considering surgical eligibility, postoperative risks, and noncancer mortality are essential to optimize outcomes.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsAdultAgedAged, 80 and overAge FactorsFemaleFollow-Up StudiesHumansMiddle AgedPrognosisRetrospective StudiesSEER ProgramSurvival RateCervical cancerElderlyPrognosisPropensity score matchingSEERSurgery

Identifiers

PMID41284201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.